CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
control clinical trial testing two different JAK Inhibitors abrocitnib, ritlecitinib, and placebo in subjects with recent onset Stage 3 Type 1 Diabetes...
Phase 2
Louisville, Kentucky, United States and 29 other locations
This study will look at the long-term effects of semaglutide (active medicine) on diabetic eye disease when compared to placebo (dummy medic...
Phase 3
Louisville, Kentucky, United States and 228 other locations
The purpose of this study is to find out if baricitinib can delay the onset of clinical type 1 diabetes (T1D) in people who are at high risk...
Phase 3
Louisville, Kentucky, United States and 106 other locations
The main purpose of this study is to evaluate additional dosing options for dulaglutide in pediatric participants with Type 2 Diabetes. Part...
Phase 3
Louisville, Kentucky, United States and 51 other locations
This investigator-initiated study will enroll about 30 adults 18 to 65 years of age with type 1 diabetes (T1D) who are using the Tandem t:sl...
Louisville, Kentucky, United States and 2 other locations
The primary objective of this study is to determine the effects of KAI-9531 administered by subcutaneous (SC) injection once weekly compared to place...
Phase 2
Louisville, Kentucky, United States and 32 other locations
fenofibrate is effective for reducing the onset of proliferative diabetic retinopathy (PDR) or and the results are adopted by the community ...
Phase 3
New Albany, Indiana, United States and 65 other locations
The study medicine will be investigated in participants with type 1 diabetes. The study will look at how well insulin icodec taken weekly co...
Phase 3
Louisville, Kentucky, United States and 183 other locations
ezetimibe 10 mg and as monotherapy, on top of guideline-recommended lipid-lowering therapy in patients with metabolic syndrome and/or Type 2 Diabetes...
Phase 3
Louisville, Kentucky, United States and 19 other locations
retatrutide dose escalation schemes in participants without type 2 diabetes who have obesity or overweight. Participation in the study will ...
Phase 3
Louisville, Kentucky, United States and 34 other locations
Clinical trials
Research sites
Resources
Legal